Herbal preparation for the treatment of COVID-19: Randomized clinical trial to test the safety and efficacy on the viral clearance of SARS-CoV-2
Phase 2
- Conditions
- Respiratory
- Registration Number
- PACTR202210816121866
- Lead Sponsor
- Faculty of Pharmacy
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
Presence of SARS-CoV-2
Respiratory rate (RR) 10-30/min PaO2/FiO2 > 300 mmHg
SatO2 >95% in AA
No organ failure
Exclusion Criteria
Patients who did not have a follow-up laboratory test
Patients with symptoms classified as severe to critical,
Patients with hepatic, renal
and/or hematological laboratory disturbances
hematological disturbances.
Severe case at least one of the following signs Respiratory rate (RR) > 30/min ;
SatO2 <93% in AA
PaO2/FiO2 < 300 mmHg
No organ failure Critical at least one of the signs Respiratory distress requiring mechanical ventilation Multi-organ failure Shock
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method